Anergy is an important mechanism of peripheral tolerance in which T cells lose the capacity to produce proinflammatory cytokines such as interleukin-2 (IL-2) and interferon-g (IFNg). To determine whether the induction of T-cell anergy in vivo is associated with epigenetic changes that oppose cytokine gene expression, we measured DNA methylation and histone acetylation at the IL2 and IFNg loci in CD4 þ T cells from mice tolerant to a viral superantigen. Tolerant T cells exhibited more DNA methylation and less histone acetylation at the regulatory regions of the IL2 and IFNg genes than effector T cells, which are able to produce IL-2 and IFNg. These data show that T-cell anergy in this model is associated with epigenetic modifications that oppose gene expression, and suggest that these mechanisms may be important in the maintenance of tolerance.
Introduction
Viral superantigens elicit strong immune responses by T cells expressing specific T-cell receptor (TCR) Vb chains. The Mls-1a superantigen is encoded by the murine retrovirus Mtv-7, and reacts with T cells bearing Vb6 þ , Vb7 þ , Vb8.1 þ and Vb9 þ TCR. 1 Like normal antigenspecific responses, Mls-1a induces T-cell activation and clonal expansion. However, unlike an immunogenic Tcell response, which results in a population of memory T lymphocytes increased in frequency and function compared to that in naive animals, Mls-1a-specific responses in vivo culminate in a population of anergic T cells that have lost the capacity to proliferate and produce proinflammatory cytokines such as IL-2 and interferong (IFNg) in response to Mls-1a, despite continued expression of an Mls-1a-reactive TCR. This state results in acquired immunological tolerance, as Mls-1a-treated recipients exhibit a defect in allograft rejection. 2 Therefore, T-cell tolerance in this model behaves like a stable, heritable trait that is maintained by daughter T cells throughout multiple rounds of cell division during the primary response.
Therefore, we have examined whether epigenetic mechanisms such as DNA methylation or histone acetylation, which alter the physical structure of the DNA and chromatin at genetic loci, may have a role in the maintenance of the Mls-1a-induced tolerant state. This hypothesis builds upon a conceptual framework assembled through a number of studies showing that TCR, co-receptor and cytokine genes are epigenetically modified as a result of T-cell development and differentiation. [3] [4] [5] [6] [7] [8] Using an established Vb8.1 TCR-transgenic mouse model, 9 we find that productive activation of Vb8.1 þ CD4 þ T cells in vitro results in strong acetylation of histones and de-methylation of CpG dinucleotides within the IL2 promoter, and to a lesser extent, the IFNg enhancer. Conversely, CD4 þ T cells from Vb8.1-transgenic mice were tolerant to Mls-1a in vivo fail to demethylate the DNA and acetylate the chromatin within the regulatory regions of these cytokine genes. Our data suggest novel molecular mechanisms that may keep proinflammatory cytokine genes in a transcriptionally repressed state during the induction and maintenance of tolerance in vivo.
Results and discussion
Tolerant CD4 þ T cells fail to epigenetically modify the IL2 promoter DNA methylation is an important epigenetic mechanism of stable gene silencing that regulates tissue development and neoplasia. 10 To determine whether DNA methylation at the IL2 promoter in Vb8.1 þ CD4 þ T cells is associated with Mls-1a-specific immunity vs tolerance, we subjected naive, anergic and effector Vb8.1 þ CD4 þ T cells to bisulfite conversion methylation analysis. This method maps the methylation status of CpG dinucleotides on individual alleles in a population of cells. To induce Mls-1a-specific CD4 þ T cell tolerance in vivo, Vb8.1 TCR-transgenic, Mls-1b þ CBA/CA mice were injected with T-cell-depleted splenocytes from Mls-1a þ CBA/J congenic mice. One week later, Vb8.1 þ CD4 þ T cells were isolated for analysis. An allelic methylation map of the proximal IL2 promoter in naive Vb8.1 þ CD4 þ T cells shows that the three most distal CpG dinucleotides at À379, À261 and À216 are unmethylated in the majority of the alleles, while the CpG dinucleotide at À68 bp is methylated in most of the alleles (Figure 1a ). Naive cells show roughly even frequencies of alleles with 0, 1, 2 and 3 methylated CpG dinucleotides, with no alleles exhibiting full Figure 1 Epigenetic modifications at the IL2 promoter. Naive (a) and tolerant (c) CD4 þ T cells were purified from Vb8.1 transgenic mice. Effector Vb8.1 þ CD4 þ T cells (b) were isolated at 72 h from in vitro Mls-1a-primed cultures. Genomic DNA was purified from each cell population, subjected to bisulfite conversion, and the IL2 promoter region was amplified, cloned and sequenced. Each row represents an individual cloned, sequenced allele (sense strand) with unmethylated and methylated CpG dinucleotides depicted as open and filled circles, respectively. Values to the right of each map represent the frequency of alleles with 0, 1, 2 and 3 methylated CpG sites, respectively. Pie charts at the bottom indicate the percent methylation (shaded) at each CpG dinucleotide across all alleles. The data shown were compiled from two separate experiments. Extracts from naive (d), effector (e) and tolerant (f) Vb8.1 þ CD4 þ T cells were also tested for histone acetylation (AcH3) at the CD3e and IL2 promoters (first and second panels). Cells were also restimulated with irradiated, T-cell-depleted CBA/J splenocytes, and IL-2 production (third panel) and thymidine incorporation (fourth panel) were assessed at 48 and 72 h, respectively. The differences between IL2 promoter AcH3, IL-2 production, and proliferation by effector cells vs naive or tolerant cells was statistically significant (Po0.05, Mann-Whitney t-test). Differences in CD3e promoter AcH3 were not statistically significant. Data are representative of two separate experiments. IL, interleukin.
methylation. Productive activation of naive Vb8 þ CD4 þ T cells with Mls-1a þ cells in vitro resulted in significant de-methylation at the proximal IL2 promoter (Figure 1b) . These effector cells exhibited de-methylation at all four CpG dinucleotides, with an overall twofold reduction in methylation as compared to that in naive T cells. The frequency of fully de-methylated alleles increased over twofold (from 30 to 73%), and the frequency of alleles with two or more methylated CpG dinucleotides dropped from 45 in naive cells to 9% in effector cells ( Figure 1b) . Next, we examined the methylation pattern of the IL2 promoter in in vivo-anergized Vb8 þ CD4 þ T cells. The level of methylation at the IL2 promoter in tolerant cells was comparable to that in the naive T cells, with the CpG site at À216 showing a 16% increase in methylation as compared to naive T cells (Figure 1c ). The frequency of fully de-methylated alleles was reduced fourfold compared to effector cells. These data suggest that the naive pattern of DNA methylation is stably inherited throughout multiple cell divisions after Mls-1a-driven clonal expansion in vivo, and that mechanisms that actively maintain methylation are operative in tolerant, but not effector, Vb8 þ CD4 þ cells. To address whether the increased DNA methylation in tolerant vs effector cells might be explained by increased expression of DNA methyltransferase (DNMT) enzymes by tolerant cells, we measured the expression of DNMT1, DNMT3a and DNMT3b genes in naive, effector and tolerant Vb8 þ CD4 þ cells in this in vivo model. While effector cells showed a selective twofold increase in DNMT1 mRNA, tolerant cells expressed the same levels of DNMT1, 3a and 3b as naive cells (data not shown). Therefore, increased DNA methylation might instead be maintained in tolerant cells through preferential recruitment of DNMT enzymes to the IL2 gene. Because DNA methylation at the IL2 promoter has been shown in two separate models to inhibit transcription of the IL2 gene, 11, 12 the increased methylation of the CpG dinucleotides within the IL2 promoter in the anergic Vb8 þ CD4 þ T cells in this model likely has a direct negative impact on the capacity of these cells to produce IL-2.
DNA methylation can act in concert with other epigenetic mechanisms such as enzymatic histone modification to keep gene loci in transcriptionally inactive vs poised states. Histone acetylation is achieved by histone acetyltransferase enzymes that are recruited by DNA-binding proteins, and acts to relax chromatin structure and increase accessibility of genes to transcriptional machinery. 13 This modification can be reversed by histone deacetylases, which promote chromatin condensation and gene silencing. 13 Histone acetylation has been shown to be associated with gain of cytokine gene expression in differentiating T cells. [14] [15] [16] [17] To determine whether the Mls-1a-induced priming vs tolerance is associated with differential histone acetylation at the IL2 promoter, we performed chromatin immunoprecipitation (ChIP) analysis on extracts of naive, in vivo anergized, and in vitro primed Vb8 þ CD4 þ T cells using antibody specific for the acetylated form of histone H3. Similar to polyclonal naive T cells, 16 ,17 the IL2 promoter in naive Vb8-transgenic CD4 þ T cells is hypo-acetylated as compared to the heavily acetylated CD3e promoter (Figure 1d ). In vitro-primed effector CD4 þ T cells, which transcribe the IL2 gene more rapidly than naive cells upon activation, 18 exhibited a 40-fold increase in histone acetylation at the IL2 promoter, and exhibited strong IL-2 production and proliferation (Figure 1e ). However, tolerant Vb8 þ CD4 þ T cells from Mls-1a-injected mice exhibited little or no increase in histone acetylation at the IL2 promoter (Figure 1f) , despite the fact that these cells were stimulated to proliferate during the primary response, and likewise failed to induce significant IL-2 production and proliferation upon re-stimulation (Figure 1f) . 17, 19 the IFNg promoter region in naive cells was generally hypo-methylated, except for the þ 17 CpG dinucleotide, which is consistently hyper-methylated in naive CD4 þ T cells (Figure 2a) . In contrast, the CpG dinucleotides in the enhancer were hyper-methylated in naive cells (Figure 2a) . The overall degree of methylation at the majority of the CpG dinucleotides in both regions did not change greatly following either activation in vitro or tolerance induction in vivo (Figure 2b ). However, CpG dinucleotides at À45, þ 462 and þ 607 were moderately de-methylated in effector Vb8 þ CD4 þ T cells compared to naive cells (Figure 2b ), but remained unchanged in tolerant Vb8 þ CD4 þ T cells (Figure 2c) . Therefore, differential regulation of DNA methylation also occurs at the IFNg locus in effector vs Mls-1a-anergized Vb8 þ CD4 þ T cells; however, these processes are not as dynamic as those operative at the IL2 promoter.
Similar to the IL2 locus, the promoter and enhancer regions of the IFNg locus in naive Vb8-transgenic CD4 þ T cells are relatively hypo-acetylated (Figure 2a , dark gray bar), as compared to the heavily acetylated CD3e promoter (Figure 2a, light gray bar) . In vitro-primed effector CD4 þ T cells, which unlike naive cells can rapidly produce IFNg upon activation, exhibited a fourfold increase at the IFNg enhancer from its higher basal level (Figure 2b , dark gray bar). However, tolerant Vb8 þ CD4 þ T cells from Mls-1a-injected mice, which do not produce IFNg upon activation (data not shown), exhibited little or no increase in histone acetylation at this region (Figure 2c , dark gray bar). These data indicate that locus-specific enforcement of histone hypoacetylation may be a general mechanism operative at proinflammatory cytokine genes in tolerant Mls-1a-reactive T cells.
We find, in a functional model of superantigeninduced tolerance, that the induction of anergy in CD4 þ T cells in vivo is associated with the failure to de-methylate and acetylate regulatory regions of proin-flammatory cytokine genes. These epigenetic changes normally occur in effector T cells, and may underlie the capacity of primed cells to rapidly express the IL2 and IFNg genes upon a second encounter with antigen. Our previous studies have shown that sialylation of cellular proteins contributes significantly to the anergic state of Vb8.1 þ CD4 þ T cells in this model, 20 and that Mls-1a-specific regulatory T cells also reinforce tolerance in Mls1a-treated mice. 21 We now identify epigenetic modifications at the IL2 and IFNg regulatory regions as processes that may also contribute to the silencing of these genes in these tolerant T cells.
We find that the majority of the CpG dinucleotides in both the IL2 and IFNg promoters are unmethylated in naive CD4 þ T cells from Vb8.1 transgenic mice, and the histones at these promoters are hypo-acetylated. This pattern of epigenetic modification is consistent with previous analyses of these promoters in monoclonal and polyclonal CD4 þ and CD8 þ T cells from naive mice, 16, 17, 19 and is typical of a gene that is epigenetically neutral (that is, neither poised nor silenced). These promoter regions are completely methylated in nonlymphoid cells that do not express the IL2 or IFNg genes, 16 and experiments in which DNA methylation at the IL2 and IFNg promoters was experimentally modulated have shown that this epigenetic modification negatively regulates gene transcription at these loci. 11, 12, 22, 23 Histone acetylation at the IFNg locus is associated with T helper 1 (Th1) differentiation, and does not occur during Th2 differentiation. 14, 15 Thus, histone acetylation during T-helper polarization is directly associated with the capacity to produce this proinflammatory cytokine. This is also the case in this Vb8.1 system, in which effector cells show significant acetylation at the intronic enhancer region, while anergic cells from Mls-1a-tolerant mice fail to acetylate this region. De-methylation of CpG dinucleotides within the IFNg intronic enhancer occurs in long-term differentiated Th1 cells, 24 as well as during CTL development in CD8 þ T cells. 17 The short-term in vitro effector differentiation in this Vb8.1 transgenic system was associated with mild de-methylation at this region, most likely because the cultures in our studies were stimulated under neutral conditions. However, no de-methylation at this region was observed in Vb8 þ CD4 þ T cells from tolerant mice.
Multiple studies have shown that T-cell division induced by productive activation drives efficient Th1 and Th2 differentiation, which correlates with acetylation and de-methylation of the IFNg and IL4 loci, respectively, in these cells. 25 However, a particularly interesting aspect of the anergic state induced in this Mls-1a model is that it develops after a phase of strong T-cell activation and proliferation. This is in contrast with other toleragenic stimuli induce a partial or abortive T-cell response, in which cell division is necessary, but not sufficient, for anergy avoidance. 26, 27 In this way, T-cell differentiation, de-methylation and acetylation of the IL2 and IFNg genes, and cell division are uncoupled from proliferation during Mls-1a-induced tolerance, and anergy in this system behaves as a heritable trait that is maintained throughout multiple rounds of cell division. How this is achieved in this model is not clear from our current studies, but does not appear to involve regulation of DNMT expression. More likely, DNMT and/or histone methyltransferases may be stably recruited to these loci by DNA-binding proteins, as has been shown for the IL4, CD4 and TdT loci in developing CD4 þ T cells. 28, 29 Our data show that toleragenic stimuli either fail to induce DNA de-methylation and chromatin remodeling at effector genes in T cells, or have engaged active mechanisms to oppose these changes, and that full activation/co-stimulation is required to engage heritable, epigenetic mechanisms that prevent gene silencing during an immune response. ) and culturing them for 5 days in the presence of a 7.5-to 10-fold excess of irradiated Mls-1 a APC purified as above. Effector CD4 þ T cells were isolated at the end of the culture period on lympholyte M (Cedarlane, Burlington, NC, USA) and washed with Hanks' balanced salt solution. IL-2 protein in 48 h supernatants was quantified using a murine IL-2 ELISA kit (eBioscience, San Diego, CA, USA) following protocol provided by the manufacturer.
Materials and methods

DNA methylation analysis
The analysis of DNA methylation at the regulatory elements of the IL2 and IFNg genes was determined by sodium bisulfite conversion followed by PCR amplification, cloning and sequencing, as described previously. 16, 17 Briefly, 1 mg of BamHI/HindIII-digested genomic DNA from purified CD4 þ T cells was incubated for 16 h at 551C with a reaction mixture containing 1.72 M sodium metabisulfite, 5.36 M urea, and 0.5 mM hydroquinone, then desalted, de-sulfonated, neutralized and ethanol precipitated. Converted DNA from the regulatory regions of the IL2 and IFNg loci was amplified using nested primer sets, 17 and cloned into pGEM-T Easy (Promega, Madison, WI, USA). Fifteen to thirty individual plasmid clones were sequenced using an M13 reverse primer, and full conversion of cytosines not located adjacent to guanines was confirmed.
Analysis of DNMT gene expression
Total, DNase-treated RNA was extracted from purified naive, tolerant and effector CD4 þ VB8 þ T cells as described previously, 16 and analyzed for murine DNMT1, DNMT3a, DNMT3b, IL-2 and 18S RNA using quantitative SYBR Green (ABI) real-time (qRT)-PCR with commercially available primer sets (SuperArray Inc., Frederick, MD, USA). Specific mRNA values were normalized to 18S RNA for each sample, and then normalized to transcript levels in naive cells.
Analysis of histone acetylation by ChIP
Histone H3 acetylation at the IL-2 and IFNg loci was quantified by ChIP analysis as described previously. 16, 17, 30 Briefly, purified CD4 þ T cells (2 Â 10 6 per reaction) were fixed for 10 min at room temperature with 1% formaldehyde, lysed and chromatin was sheared by sonication. Chromatin was precleared and immunoprecipitated overnight at 41C with anti-acetylated H3 Ab (Upstate, Charlottesville, VA, USA) or non-specific rabbit IgG. DNA was extracted from pre-and post-precipitation fractions, and quantitative SYBR Green (ABI) real-time (qRT)-PCR was performed using primers specific for the IL-2, IFNg and CD3e promoters and the IFNg intron I enhancer. Histone acetylation is expressed as a signal-tonoise ratio, determined by normalizing the post-ChIP signals for each reaction to the pre-ChIP input signal for each cell population, then normalized to the background IgG ChIP signal for each cell population.
